_256_384.jpg)
Medical Device | November 01, 2021
Holborn Wells and SpeedBio India forms JV to manufacture in vitro diagnostics
Both parties are expected to invest a total of US $ 1 million to establish the brand
Both parties are expected to invest a total of US $ 1 million to establish the brand
The NFI is published to promote the rational use of medicines in the country.
It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology
Acute therapies continue to report strong growth compared to chronic ones.
Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications
This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
This strategic collaboration will enable continued innovation in cancer care
Subscribe To Our Newsletter & Stay Updated
